chr11-5226626-A-G
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000518.5(HBB):c.266T>C(p.Leu89Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L89R) has been classified as Likely benign.
Frequency
Consequence
NM_000518.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HBB | NM_000518.5 | c.266T>C | p.Leu89Pro | missense_variant | 2/3 | ENST00000335295.4 | NP_000509.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBB | ENST00000335295.4 | c.266T>C | p.Leu89Pro | missense_variant | 2/3 | 1 | NM_000518.5 | ENSP00000333994.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 36
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Sep 02, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 01, 2017 | The Hb Santa Ana variant (HBB: c.266T>C; Leu88Pro) (rs33940204) has been reported in a heterozygous state in multiple individuals with hemolytic anemia, jaundice and splenomegaly (Fairbanks 1969, Opfell 1968, HbVar database and references therein). It has also been reported as a de-novo alteration in an affected individual, which co-segregated with clinical symptoms in the subsequent generation (Opfell 1968). Functional characterization of the variant hemoglobin indicates reduced stability and increased formation of inclusion bodies, while tetramers containing the variant hemoglobin are bound to two heme groups instead of four (Opfell 1968). Another missense variant at this position, Leu88Arg, has also been implicated as an unstable hemoglobin resulting in similar clinical symptoms when found in a heterozygous state (Hollender 1969). The Leu88Pro variant is listed in ClinVar (Variation ID: 15343), but is not observed in the general population databases (1000 Genomes Project, Exome Variant Server, Genome Aggregation Database). The leucine at position 88 is highly conserved (Alamut v2.10), and is located in the heme-binding pocket of the protein (Hollender 1969, Opfell 1968). Computational algorithms (Align GVGD, Mutation Taster, PolyPhen-2, SIFT) predict that the Leu88Pro variant has an impact on HBB protein structure or function. Based on the above information, the Hb Santa Ana variant is classified as pathogenic. References: Link to HbVar database for Hb Santa Ana: http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=output&display_format=page&i=420 Fairbanks V et al. Three families with unstable hemoglobinopathies (Köln, Olmsted and Santa Ana) causing hemolytic anemia with inclusion bodies and pigmenturia. Am J Med. 1969; 46(3):344-59. Hollender A et al. New unstable haemoglobin borås: beta 88 (F4) leucine-arginine. Nature. 1969; 222(5197):953-5. Opfell R et al. Hereditary non-spherocytic haemolytic anaemia with post-splenectomy inclusion bodies and pigmenturia caused by an unstable haemoglobin Santa Ana-beta-88 (F4) leucine--proline. J Med Genet. 1968; 5(4):292-7. - |
Beta-thalassemia HBB/LCRB Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein | Sep 27, 2022 | ACMG classification criteria: PS3 supporting, PS4 moderated, PM2 moderated, PM6 moderated, PP3 supporting - |
HEMOGLOBIN SANTA ANA Other:1
other, no assertion criteria provided | literature only | OMIM | Dec 12, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at